PACTR201909691980023Other1 期
Evaluation of the Use of Hypertonic Saline 3% Nebulizer versus intravenous hypertonic saline 3% to attenuate the Manifestations of Acute Respiratory Distress Syndrome
amr sobhy abdelkway0 个研究点目标入组 104 人开始时间: 2019年9月9日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- Other
- 发起方
- 入组人数
- 104
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 45 Year(s) 至 64 Year(s)（—）
- 性别
- All
入选标准
- •age of 18-60 years
- •fulfilling Berlin definition of ARDS as follows:
排除标准
- •Presence of heart failure or evidence of fluid overload
- •renal failure
- •hyperventilate patient
- •refuse to anticipate
研究者
相似试验
已完成
3 期
Does Nebulized 3% Hypertonic Saline Shorten the Duration of Hospitalization in Preschool Children with Acute Wheezing?preschool wheezinghypertonic salinelength of stayrandomized controlled trialTCTR20170327001none50
招募中
2 期
Effect of hypertonic saline3% in tramadol toxicityAcute tramadol toxicity and side effects.IRCT20220213054017N1Artesh University of Medical Sciences200
已完成
2 期
the effect of Nebulized Hypertonic3% Saline in the Treatment of Acute bronchiolitis in pediatric wardbrochiolitis.Acute bronchiolitis due to respiratory syncytial virusIRCT2012110510222N2Vice Chancellor for Research, Shahrekord Univrsity of Medical Sciences70
已完成
不适用
A comparison of nebulized 3% hypertonic saline and epinephrine versus nebulized normal saline and epinephrine in the treatment of acute bronchiolitisRespiratoryBronchiolitisISRCTN66632312niversity of Alberta, Department of Pediatrics (Canada)46
招募中
3 期
Advantages of using 5% hypertonic saline nebulization over 3% saline nebulization in children with Acute BronchiolitisCTRI/2017/08/009351Dean Research JIPMER